Wealth Enhancement Advisory Services’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $785K | Sell |
4,999
-724
| -13% | -$114K | ﹤0.01% | 1881 |
|
|
2025
Q1 | $861K | Sell |
5,723
-247
| -4% | -$37.2K | ﹤0.01% | 1675 |
|
|
2024
Q4 | $1.1M | Buy |
5,970
+187
| +3% | +$34.5K | ﹤0.01% | 1476 |
|
|
2024
Q3 | $1.14M | Sell |
5,783
-331
| -5% | -$65.2K | ﹤0.01% | 1314 |
|
|
2024
Q2 | $1.26M | Buy |
6,114
+1,535
| +34% | +$317K | ﹤0.01% | 1172 |
|
|
2024
Q1 | $1.24M | Sell |
4,579
-37
| -0.8% | -$10K | ﹤0.01% | 1140 |
|
|
2023
Q4 | $1.09M | Buy |
4,616
+63
| +1% | +$14.9K | ﹤0.01% | 1138 |
|
|
2023
Q3 | $892K | Buy |
+4,553
| New | +$892K | ﹤0.01% | 1149 |
|
|
2021
Q4 | – | Sell |
-19,303
| Closed | -$8.3M | – | 306 |
|
|
2021
Q3 | $8.3M | Buy |
+19,303
| New | +$8.3M | 0.12% | 82 |
|